Our portfolio

We hold and develop strategic interests in spin-offs whose work aligns with our experience in food systems, bioproducts, formulation and delivery technologies.

Food & bioproducts

Sustainable Bioproduct Innovations

SBI advances sustainable food and bioproduct technologies toward commercial production. Its flagship platform includes 0Fat™, a clean-label, plant-derived fibre system designed to reduce or replace conventional fats while supporting desirable texture and functionality.

Visit company website

Biotechnology

Insu Therapeutics

Insu Therapeutics is developing a proprietary buccal delivery platform intended to enable selected peptide therapeutics to be absorbed through the oral mucosa. Development programs include insulin and GLP-1 therapies.

Visit company website

Blue Panthers holds strategic interests in independently governed portfolio companies. Portfolio-company activities, products, claims, financing and regulatory matters are the responsibility of the applicable portfolio company.